<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Alterations in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor genes p53, p16, and fhit were studied in <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) samples of Indian patients </plain></SENT>
<SENT sid="1" pm="."><plain>PCR-SSCP analysis showed evidence for the presence of polymorphism in fhit gene in 7 of 15 samples </plain></SENT>
<SENT sid="2" pm="."><plain>We failed to get any evidence for mutation in the p53, p16, and fhit genes </plain></SENT>
<SENT sid="3" pm="."><plain>These results indicate that mutational inactivation of these genes may not play a major role in the development of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
</text></document>